LAT-B,
latrunculin B,
latrunculin B,
LAT-B,
76343-94-7,
UNII-LW7U308U7U,
LW7U308U7U,
CHEBI:49703,
Latrunculin B, Latrunculia magnifica,
(4R)-4-[(1R,4Z,8Z,10S,13R,15R)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-1,3-thiazolidin-2-one,
C20H29NO5S,
NSC339663,
NSC-339663,
(4R)-4-[(1R,4S,5Z,9Z,13R,15R)-15-hydroxy-4,9-dimethyl-11-oxo-12,16-dioxabicyclo[11.3.1]heptadeca-5,9-dien-15-yl]-1,3-thiazolidin-2-one,
Lat B,
(+)-latrunculin B,
NSC 339663,
AC1O5L9Q,
BSPBio_001189,
AC1Q29P5,
CHEMBL411879,
SCHEMBL2531366,
BCBcMAP01_000226,
HMS1362K11,
HMS1792K11,
HMS1990K11,
HMS3403K11,
ZINC5751767,
1814AH,
MFCD00270879,
AKOS032947159,
DB08080,
Latrunculin B from Latruncula magnifica,
IDI1_002180,
SMP2_000317,
NCGC00163459-03,
2-Thiazolidinone, 4-(15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo(11.3.1)heptadeca-4,8-dien-15-yl)-, (1R*,4Z,8Z,10S*,13R*,15R*(R*))-(+)-,
BRD-K30455030-001-03-3,
Latrunculin B from Latruncula magnifica, >=80% (HPLC), solid,
(4R)-[(1R,4Z,8Z,10S,13R,15R)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-2-thiazolidinone,
(4R)-4-[(1R,4S,5Z,9Z,13R,15R)-15-hydroxy-4,9-dimethyl-11-oxo-12,16-dioxabicyclo[11.3.1]heptadeca-5,9-dien-15-yl]thiazolidin-2-one,
2-Thiazolidinone, 4-[(1R,4Z,8Z,10S,13R,15R)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-, (4R)-,
LATRUNCULINB,
D07EHB,
C20-H29-N-O5-S,
CID6436219,
INS-115644,
C037068,
Cytoskeleton-targeting compounds (glaucoma), Wisconsin Alumni Research Foundation (WARF)/Inspire,
LAB,